Skip to main content
Log in

Compensatory responses to increased mechanical abnormalities in COPD during sleep

  • Original Article
  • Published:
European Journal of Applied Physiology Aims and scope Submit manuscript

Abstract

Purpose

To assess whether night-time increases in mechanical loading negatively impact respiratory muscle function in COPD and whether compensatory increases in inspiratory neural drive (IND) are adequate to stabilize ventilatory output and arterial oxygen saturation, especially during sleep when wakefulness drive is withdrawn.

Methods

21 patients with moderate-to-severe COPD and 20 age-/sex-matched healthy controls (CTRL) participated in a prospective, cross-sectional, one-night study to assess the impact of COPD on serial awake, supine inspiratory capacity (IC) measurements and continuous dynamic respiratory muscle function (esophageal manometry) and IND (diaphragm electromyography, EMGdi) in supine sleep.

Results

Supine inspiratory effort and EMGdi were consistently twice as high in COPD versus CTRL (p < 0.05). Despite overnight increases in awake total airways resistance and dynamic lung hyperinflation in COPD (p < 0.05; not in CTRL), elevated awake EMGdi and respiratory effort were unaltered in COPD overnight. At sleep onset (non-rapid eye movement sleep, N2), EMGdi was decreased versus wakefulness in COPD (− 43 ± 36%; p < 0.05) while unaffected in CTRL (p = 0.11); however, respiratory effort and arterial oxygen saturation (SpO2) were unchanged. Similarly, in rapid eye movement (stage R), sleep EMGdi was decreased (− 38 ± 32%, p < 0.05) versus wakefulness in COPD, with preserved respiratory effort and minor (2%) reduction in SpO2.

Conclusions

Despite progressive mechanical loading overnight and marked decreases in wakefulness drive, inspiratory effort and SpO2 were well maintained during sleep in COPD. Preserved high inspiratory effort during sleep, despite reduced EMGdi, suggests continued (or increased) efferent activation of extra-diaphragmatic muscles, even in stage R sleep.

Clinical trial information

The COPD data reported herein were secondary data (Placebo arm only) obtained through the following Clinical Trial: “Effect of Aclidinium/Formoterol on Nighttime Lung Function and Morning Symptoms in Chronic Obstructive Pulmonary Disease” (https://clinicaltrials.gov/ct2/show/NCT02429765; NCT02429765).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Code availability

Not applicable.

Abbreviations

R AW :

Airway resistance

CO2 :

Carbon dioxide

COPD:

Chronic obstructive pulmonary disease

ECG:

Electrocardiography

EELV:

End-expiratory lung volume

EMG:

Electromyography

EMGdi:

Diaphragmatic electromyography

EOG:

Electrooculography

EELV:

End-expiratory lung volume

F B :

Breathing frequency

FEV1 :

Forced expired volume in 1 s

FRC:

Functional residual capacity

FVC:

Forced vital capacity

IC:

Inspiratory capacity

ICS:

Inhaled corticosteroids

IND:

Inspiratory neural drive

N2:

Stage 2 non-rapid eye movement sleep

NMD:

Neuro-mechanical dissociation

O2 :

Oxygen

Pdi:

Transdiaphragmatic pressure

Pes:

Esophageal pressure

P ETCO2 :

End-tidal partial pressure of carbon dioxide

Pga:

Gastric pressure

PFT(s):

Pulmonary function test(s)

PL:

Placebo

PSG:

Polysomnography

Stage R Sleep:

Rapid eye movement stage sleep

RV:

Residual volume

TLC:

Total lung capacity

VC:

Vital capacity

\(\dot{V}{\text{CO}}_{2}\) :

Carbon dioxide production

\(\dot{V}_{{\text{E}}}\) :

Minute ventilation

\(\dot{V}{\text{O}}_{2}\) :

Oxygen consumption

V T :

Tidal volume

References

Download references

Funding

This study was supported by a Canadian Institutes of Health Research Banting Postdoctoral Fellowship (N.J. Domnik) as well as a William M Spear Endowment Fund in Pulmonary Research from the Faculty of Health Sciences at Queen’s University and an investigator-initiated grant from AstraZeneca Canada Inc (ESR-15-10942), which included the Aclidinium Bromide/Formoterol 400/12 mcg (Duaklir) and placebo inhalers used in this study. The funders had no role in study design, data collection, analysis, or interpretation. D.B. Phillips was funded by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. A.F. Elbehairy acknowledges the support of the European Respiratory Society (Fellowship LTRF 2019).

Author information

Authors and Affiliations

Authors

Contributions

NJD, JAN, HSD, and DEO’D contributed significantly to the design of the study. NJD and HSD contributed significantly to data acquisition. NJD, DBP, MDJ, RES, GAA, SMT, and ATDL contributed significantly to data analysis. All authors contributed significantly to data interpretation. NJD and DEO’D contributed significantly to drafting the work. All authors contributed to critically revising the work. All authors approved the final version of the work submitted for publication and agree to be accountable for all aspects of the work, including ensuring that any questions related to accuracy or integrity are investigated and resolved.

Corresponding author

Correspondence to Denis E. O’Donnell.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethics approval

The procedures used in this study were approved by the Queen’s University Health Sciences’ Research Ethics Board (REB # 6015908).

Consent to participate

All participants provided written informed consent prior to participation in this study.

Consent to publish

Participants were made aware of future plans to publish anonymised data resulting from the study during the informed consenting process.

Additional information

Communicated by Susan Hopkins .

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 200 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Domnik, N.J., Phillips, D.B., James, M.D. et al. Compensatory responses to increased mechanical abnormalities in COPD during sleep. Eur J Appl Physiol 122, 663–676 (2022). https://doi.org/10.1007/s00421-021-04869-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00421-021-04869-0

Keywords

Navigation